Top Markets
Coin of the day
UniPharma Co., Ltd. UniPharma Co., Ltd.

UniPharma Co., Ltd.

6621
Classement en actions #31500
UniPharma Co., Ltd. is a Taiwanese enterprise specializing in the distribution... UniPharma Co., Ltd. is a Taiwanese enterprise specializing in the distribution of pharmaceuticals, medical apparatus, and diagnostic kits. Its diagnostic portfolio encompasses various medical disciplines, including oncology, gynecology, orthopedics, neurology, anesthesiology, and cardiology. The company's offerings feature products such as Adept reduction solution, anesthetic injections (including bain, esmolol HCI, and naloxone), the Elisa DR-70 test for in-vitro tumor detection, and Fomeject antidote injections. Furthermore, UniPharma extends its services to include drug development, research and development, clinical studies, and marketing. Its client base includes major medical centers, regional hospitals, and local clinics. Founded in 1998, UniPharma is headquartered in Taipei, Taiwan.
Prix de l'action
$0.36091897
Capitalisation boursière
$13.01M
Changement (1 jour)
-1.73%
Changement (1 an)
-12.93%
Pays
TW
Échange UniPharma Co., Ltd. (6621)

Catégorie

Ratio P/B pour UniPharma Co., Ltd. (6621)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de UniPharma Co., Ltd., le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour UniPharma Co., Ltd. de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes